Google Academic

Más Info
PUBLICACIONES EN REVISTAS INTERNACIONALES (Años 70)
  1. L. Carrasco y D. Vázquez. Survey of inhibitors in different steps of protein synthesis by mammalian ribosomes. J. Antibiotics 25, 732-736 (1972).
  2. L. Carrasco, M. Barbacid y D. Vázquez. The trichodermin group of antibiotics, inhibitors of peptide bond formation by eukaryotic ribosomes. Biochim. Biophys. Acta 312, 368-376 (1973).
  3. L. Carrasco y D. Vázquez. Differences in eukaryotic ribo-somes detected by the selective action of an antibiotic. Biochim. Biophys. Acta 319, 209-215 (1973).
  4. L. Carrasco y D. Vázquez. Ribosomal sites involved in binding of aminoacyl-tRNA and eIF-2. Mode of action of fusidic acid. FEBS Lett. 32, 152-156 (1973).
  5. C. Fernández-Puentes, L. Carrasco y D. Vázquez. The enhancement of polypeptide synthesis in mammalian systems by methylxanthines. FEBS Lett. 45, 132-135 (1974).
  6. L. Carrasco y D. Vázquez. The involvement of sulphydryl groups in the peptidyl transferase centre of eukaryotic ribosomes. Eur. J. Biochem. 50, 317-323 (1975).
  7. L. Carrasco, M. Fresno y D. Vázquez. Narciclasine: An antitumor alkaloid which blocks peptide bond formation by eukaryotic ribosomes. FEBS Lett. 52, 236-239 (1975).
  8. L. Carrasco, C. Fernández-Puentes y D. Vázquez. Effects of ricin on the ribosomal sites involved in the interaction of the elongation factors. Eur. J. Biochem. 54, 499-503 (1975).
  9. S. Olsnes, C. Fernández-Puentes, L. Carrasco y D. Vázquez. Ribosome inactivation by the toxic lectins abrin and ricin. Kinetics of the enzymatic activity of the toxin A-chains. Eur. J. Biochem. 60, 281-288 (1975).
  10. L. Carrasco, C. Fernández-Puentes y D. Vázquez. Antibiotics and compounds affecting translation by eukaryotic ribosomes. Specific enhancement of aminoacyl-tRNA binding by methylxantines. Mol. Cell. Biochem. 10, 97-122 (1976).
  11. L. Carrasco, A. Jiménez y D. Vázquez. Specific inhibition of trans-location by tubulosine in eukaryotic polysomes. Eur. J. Biochem. 64, 1-5 (1976).
  12. R. Reyes, L. Carrasco y D. Vázquez. Binding of aminoacyl-tRNA to rat liver ribosomal proteins. Mol. Biol. Reports 2, 471-477 (1976).
  13. M. Fresno, L. Carrasco y D. Vázquez. Inhibition of the polypeptide chain reticulocyte cell-free systems. Survey of different inhibitors of translation. Eur. J. Biochem. 68, 355-364 (1976).
  14. C. Fernández-Puentes, L. Carrasco y D. Vázquez. The site of action of ricin on the ribosome. Biochemistry 15, 4364-4369 (1976).
  15. L. Carrasco y A.E. Smith. Sodium ions and the shut-off of host cell protein synthesis by picornavirus. Nature 264, 807-809 (1976).
  16. L. Carrasco. The inhibition of cell function after viral infection. A proposed general mechanism. FEBS Lett. 76, 11-15 (1977).
  17. A. Jiménez, L. Carrasco y D. Vázquez. Enzymic and non-enzymic translocation by yeast polysomes. Site of action of a number of inhibitors. Biochemistry 16, 4727-4730 (1977).
  18. L. Carrasco. Membrane leakiness after viral infection and a new approach to the development of antiviral agents. Nature 272, 694-699 (1978).
  19. A. Contreras, D. Vázquez y L. Carrasco. Inhibition by selected antibiotics of protein synthesis in cells growing in tissue culture. J. Antibiotics 31, 598-602 (1978).
  20. A. Contreras y L. Carrasco. Selective inhibition of protein synthesis in virus-infected mammalian cells. J. Virol. 29, 114-122 (1979).
REVISTAS NACIONALES
  1. C. Vicente, L. Carrasco, J. Carreira, R. Manso y A. Martin. Efecto de aminoácidos sobre la biosíntesis de ureasa en Proteus mirabilis. Revista de la Real Academia de Ciencias Exactas, Físicas y Naturales de Madrid 64, 838-842 (1970).
  2. L. Carrasco. Estudios sobre la expresión genética de virus animales. Fundación Juan March. Serie Universitaria, vol. 57 (1978).
  3. L. Carrasco. Biología Molecular de los virus animales. In Cuadernos de Biología Molecular, vol. 1 (J.M. Fernández-Sousa, ed.), Madrid (1979).
PUBLICACIONES EN REVISTAS INTERNACIONALES (Años 80)
  1. M.A. Alonso, D. Vázquez y L. Carrasco. Compounds affecting the membrane inhibit protein synthesis in yeast. Antimicrob. Agents. Chemother. 16, 750-756 (1980).
  2. L. Carrasco y A.E. Smith. Molecular biology of animal virus infection. Pharmac. Ther. 9, 311-355 (1980).
  3. M.A. Alonso y L. Carrasco. Action of membrane-active compounds on mammalian cells. 1. Permeabilization of human cells by ionophores to inhibitors of translation and transcription. Eur. J. Biochem. 109, 535-540 (1980).
  4. C. Fernández-Puentes y L. Carrasco. Viral infection permeabilizes mammalian cells to protein toxins. Cell 20, 769-775 (1980).
  5. L. Carrasco. Selective inhibition of translation in transformed cells. FEBS Lett. 110, 341-343 (1980).
  6. L. Carrasco. Action of nucleotide derivatives on translation in encephalomyocarditis virus-infected mouse cells. J. Gen. Virol. 54, 125-134 (1981).
  7. A. Benedetto, G.B. Rossi, C. Amici, F. Belardelli, L. Cioé, G. Carruba y L. Carrasco. Inhibition of animal virus production by means of translation inhibitors impermeable to normal cells. Virology 106, 123-132.(1980).
  8. J.C. Lacal, D. Vázquez, J.M. Fernández-Sousa y L. Carrasco. Antibiotics that specifically block translation in virus-infected cells. J. Antibiotics 33, 441-446 (1980).
  9. M.A. Alonso y L. Carrasco. Reversion by hypotonic medium of the shut-off protein synthesis induced by encephalomyocarditis virus. J. Virol. 37, 535-540 (1981).
  10. L. Carrasco, D. Vázquez, C. Hernández-Lucas, P. Carbonero y F. García-Olmedo. Thionins: Plant peptides that modify membrane permeability in cultured mammalian cells. Eur. J. Biochem. 116, 185-189 (1981).
  11. M.A. Alonso y L. Carrasco. Relationship between membrane permeability and the translation capacity of human HeLa cells studied by means of the ionophore nigericin. Eur. J. Biochem. 118, 289-294 (1981).
  12. M.A. Alonso y L. Carrasco. Permeabilization of mammalian cells to proteins by the ionophore nigericin. FEBS Lett. 127, 112-114 (1981).
  13. M.A. Alonso y L. Carrasco. Selective inhibition of cellular protein synthesis by amphotericin B in EMC-infected cells. Virology 114, 247-251 (1981).
  14. L. Carrasco. Modification of membrane permeability induced by animal viruses early in infection. Virology 113, 623-629 (1981).
  15. A. Muñoz y L. Carrasco. Protein synthesis and membrane integrity in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Gen. Virol. 56, 153-162 (1981).
  16. A. Muñoz y L. Carrasco. Reversal by hypotonic medium of the antiviral state induced by lymphoblastoid interferon in human HeLa cells. Intervirology 16, 106-113 (1981).
  17. L. Carrasco y M. Esteban. Modification of membrane permeability in vaccinia virus-infected cells. Virology 117, 62-69 (1982).
  18. M.A. Alonso y L. Carrasco. Translation of capped viral mRNA in encephalomyocarditis virus-infected cells. J. Gen. Virol. 60, 315-325 (1982).
  19. M.A. Alonso y L. Carrasco. Molecular basis of the permeabilization of mammalian cells by ionophores. Eur. J. Biochem. 127, 567-569 (1982).
  20. M.A. Alonso y L. Carrasco. Protein synthesis in HeLa cells double-infected with encephalomyocarditis virus and poliovirus. J. Gen. Virol. 61, 15-24 (1982).
  21. J.C. Lacal y L. Carrasco. Relationship between membrane integrity and the inhibition of host translation in virus-infected mammalian cells. Comparative studies between encephalomyocarditis virus and poliovirus. Eur. J. Biochem. 127, 359-366 (1982).
  22. M.A. Alonso y L. Carrasco. Translation of capped viral mRNAs in poliovirus-infected HeLa cells. EMBO J. 1, 913-917 (1982).
  23. J.C. Lacal y L. Carrasco. Modification of membrane permeability in poliovirus-infected HeLa cells. Effect of guanidine. J. Gen. Virol. 64, 787-793 (1983).
  24. A. Muñoz y L. Carrasco. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J. Gen. Virol. 65, 1069-1078 (1984).
  25. A. Muñoz y L. Carrasco. Do cells treated with human interferon survive virus infection?. FEMS Lett. 20, 317-321 (1983).
  26. A. Muñoz y L. Carrasco. Comparison of the antiviral action of different human interferon against DNA and RNA viruses. FEMS Lett. 21, 105-111 (1984).
  27. A. Muñoz y L. Carrasco. Effect of interferon treatment on blockade of protein synthesis induced by poliovirus infection. Eur. J. Biochem. 137, 623-629 (1983).
  28. A. Muñoz, R. Harvey y L. Carrasco. Cellular RNA is not degraded in interferon-treated HeLa cells after poliovirus infection. FEBS Lett. 160, 87-92 (1983).
  29. A. Muñoz, L. Carrasco y M. Fresno. Enhancement of susceptibility of HSV-1 infected cells to natural killer lysis by interferon. J. Immunol. 131, 783-787 (1983).
  30. L. Carrasco y J.C. Lacal. Permeabilization of cells during animal virus infection. Pharmacol. Ther. 23, 109-145 (1983).
  31. J.C. Lacal y L. Carrasco. Antiviral effects of hygromycin B, a translation inhibitor nonpermeant to uninfected cells. Antim. Agents Chemoth. 24, 273-275 (1983).
  32. A. Muñoz y L. Carrasco. Action of human lymphoblastoid interferon on HeLa cells infected with RNA containing animal viruses. J. Gen. Virol. 65, 377-390 (1984).
  33. B. Alarcón, J.C. Lacal, J.M. Fernández-Sousa y L. Carrasco. Screening for new compounds with antiherpes activity. Antiviral Res. 4, 231-243 (1984).
  34. A. Muñoz, M.A. Alonso y L. Carrasco. Synthesis of heat-shock proteins in HeLa cells. Inhibition by virus infection. Virology 137, 150-159 (1984).
  35. B. Alarcón, M.E. González y L. Carrasco. Antiherpes action of atropine. Antimicr. Agents Chemoth. 26, 702-706 (1984).
  36. M.J. Otero y L. Carrasco. Action of oligomycin on cultured mammalian cells. Permeabilization to translation inhibitors. Mol. Cell. Biochem. 61, 183-191 (1984).
  37. J.M. Camarasa, J.M. Fernández-Sousa, M.T. García López, F.D. de las Heras, P. Méndez-Castrillón, B. Alarcón y L. Carrasco. UDP-glucose analogs: a new type of antiviral compounds that block protein glycosylation. J. Med. Chem. 28, 40-46 (1985).
  38. L. Carrasco y D. Vázquez. Molecular bases for the action and selectivity of nucleoside antibiotics. Medicinal Research Reviews 4, 471-512 (1984).
  39. B. Alarcón, H. Bugany y L. Carrasco. pppA2p5'A blocks vesicular stomatitis virus replication in intact cells. J. Virol. 52, 183-187 (1984).
  40. R. Alonso, J.I. Andrés, M.T. García-López, F.G. de las Heras, R. Herranz, B. Alarcón y L. Carrasco. Synthesis and antiviral evaluation of nucleosides of 5-methyl inidazole-4-carboxamine. J. Med. Chem. 28, 834-838 (1985).
  41. E. Feduchi, M. Cosin y L. Carrasco. Mildiomycin: a nucleoside antibiotic that blocks protein synthesis. J. Antibiotics 38, 415-419 (1985).
  42. J.L. Castrillo y L. Carrasco. Increased inhibition of cellular RNA synthesis by alpha-amanitin during entry of viruses into animal cells. FEMS Lett. 26, 221-225 (1985).
  43. A. Muñoz, M.A. Alonso y L. Carrasco. The regulation of translation in reovirus-infected cells. J. Gen. Virol. 66, 2161-2179 (1985).
  44. A. Muñoz, J.L. Castrillo y L. Carrasco. Modification of membrane permeability during Semliki Forest Virus infection. Virology 146, 203-212 (1985).
  45. M.J. Camarasa, P. Fernández-Resa, M.T. García-López, F.G. de las Heras, P.P. Méndez-Castrillón, B. Alarcón y L. Carrasco. Analogues of uridine disphosphate hexoses. A new type of protein glycosylation inhibitors that show antiviral activity. Nucleosides and Nucleotides 4, 149-151 (1985).
  46. B. Alarcón, A. Zerial, C. Dupiol y L. Carrasco. The antirhinovirus compound 44081 R.P. inhibits virus uncoating. Antim. Ag. Chemoth. 30, 31-34 (1986).
  47. A. Sola, S. Rodríguez, C. Gil-Fernández, B. Alarcón y L. Carrasco. New antiviral agents active against african swine fever virus. Antim. Ag. Chemoth. 29, 284-288 (1986).
  48. L. Carrasco y R. Bravo. Specific proteins synthesized during the viral lytic cycle in vaccinia-infected HeLa cells. Analysis by high resolution two dimensional gel electrophoresis. J. Virol. 58, 569-577 (1986).
  49. J.L. Castrillo, D.A. Van denVerghe y L. Carrasco. 3-methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virology 152, 219-227 (1986).
  50. J.L. Castrillo y L. Carrasco. The inhibition of nucleic acid synthesis in encephalomyocarditis virus-infected L929 cells: Effects on nucleoside transport. Mol. Cell. Biochem. 71, 53-60 (1986).
  51. M.J. Otero y L. Carrasco. External ATP permeabilizes transformed cells to macromolecules. Biochim. Biophys. Res. Commun. 134, 453-460 (1986).
  52. J.L. Castrillo, A. López-Rivas y L. Carrasco. Effects of extracellular cations in poliovirus-infected cells. J. Gen. Virol. 68, 325-333 (1987).
  53. A. López-Rivas, J.L. Castrillo y L. Carrasco. Cation content in poliovirus-infected HeLa cells. J. Gen. Virol. 68, 335-342 (1987).
  54. J. Fiandor, M.T. García-López, F.G. de las Heras, P.P. Méndez-Castrillón, A. San Félix, B. Alarcón y L. Carrasco. Hexose-modified antiviral analogues of uridine 5'-diphosphate glucose derivatives. Eur. J. Biochem. 22, 59-65 (1987).
  55. M.J. Otero y L. Carrasco. Control of membrane permeability in animal cells by calcium ions. Exp. Cell. Res. 169, 531-542 (1987).
  56. J.C. de la Torre, B. Alarcón, E. Martínez-Salas, L. Carrasco y E. Domingo. Ribavirin cures cells of a persistent infection with foot and mouth disease virus in vitro. J. Virol. 61, 233-235 (1987).
  57. P. Fernández-Resa, M.T. García-López, F.G. de las Heras, A. San Félix, B. Alarcón y L. Carrasco. Diphosphate modified antiviral analogues of uridine 5'-diphosphate glucose derivatives. Eur. J. Med. Chem. 21, 245-249 (1987).
  58. E. Feduchi y L. Carrasco. Adenovirus infection reverses the antiviral state induced by human interferon. FEBS Lett. 214, 153-157 (1987).
  59. J.L. Castrillo y L. Carrasco. Adenovirus late protein synthesis is resistant to the inhibition of translation induced by poliovirus. J. Biol. Chem. 262, 7328-7334 (1987).
  60. M.J. Otero y L. Carrasco. Proteins are cointernalyzed with virion particles during early infection. Virology 160, 75-80 (1987).
  61. L. Carrasco. Baciphelacin: A new eukaryotic translation inhibitor. Biochimie 69, 797-802 (1987).
  62. M.E. González, B. Alarcón y L. Carrasco. Polysaccharides as antiviral agents. Antiviral activity of carrageenan. Ant. Agents. Chemoth. 31, 1388-1393 (1987).
  63. J.L. Castrillo y L. Carrasco. Action of 3-methyl-quercetin on poliovirus RNA replication. J. Virol. 61, 3319-3321 (1987).
  64. A. Urzainqui, E. Tabarés y L. Carrasco. Proteins synthesized in African swine fever virus-infected cells analyzed by two dimensional gel electrophoresis. Virology 160, 286-291 (1987).
  65. M.E. González y L. Carrasco. Animal viruses promote the entry of polysaccharides with antiviral activity into cells. Biochem. Biophys. Res. Commun. 146, 1303-1310 (1987).
  66. L. Carrasco, M.J. Otero y J.L. Castrillo. Modification of membrane permeability by animal viruses. Pharmac. Ther. 40, 171-212 (1989).
  67. B. Alarcón, J.M. Redondo, H. Bugany, L. Carrasco y M. Fresno. Inhibition of natural killer cytotoxicity by extracellular ppp(A2'p5')nA oligonucleotides. Int. J. Immunopharmacol. 10, 73-80 (1987).
  68. J.L. Castrillo, A. Urzainqui y L. Carrasco. The P2 and P3 regions of the poliovirus genome are preferentially translated at alkaline pH in infected HeLa cells. J. Gen. Virol. 69, 583-590 (1988).
  69. B. Alarcón, M.E. González y L. Carrasco. Megalomycin C, a macrolide antibiotic that shows antiviral activity and blocks protein glycosylation. FEBS Lett. 231, 207-211 (1988).
  70. A. Alcina, A. Urzainqui y L. Carrasco. The heat-shock response in T. cruzi. Eur. J. Biochem. 172, 121-127 (1988).
  71. B. Alarcón, M.E. González, L. Carrasco, P. Méndez-Castrillón, M.T. García-López y F.G. de las Heras. Mode of action of a new type of uridine-5'-diphosphate glucose analogues against herpesvirus replication. Ant. Agents Chemoth. 32, 1257-1261 (1988).
  72. M.J. Otero y L. Carrasco. Exogenous phospholipase C permeabi-lizes mammalian cells to proteins. Exp. Cell Res. 177, 154-161 (1988).
  73. E. Feduchi, M. Esteban y L. Carrasco. Reovirus type 3 synthesizes proteins in interferon-treated HeLa cells without reversing the antiviral state. Virology 164, 420-425 (1988).
  74. C. de Diego, C. Avendaño, A. Alcina, L. Carrasco y J. Elguero. Effect of heterocyclic analogues of triphenylmethane dyes against Trypanosoma cruzi. Ann. Trop. Medic. Parasitol. 82, 235-241 (1988).
  75. J.A. López-Guerrero, L. Carrasco, M. Fresno y M.A. Alonso. Restriction of poliovirus RNA translation in a human monocytic cell line. Eur. J. Biochem. 186, 577-582 (1989).
  76. A. Urzainqui y L. Carrasco. Post-translational modifications of polio-virus proteins. Biochem. Biophys. Res. Commun. 158, 263-271 (1989).
  77. A. Urzainqui y L. Carrasco. Degradation of cellular proteins during poliovirus infection studied by 2-D gel electrophoresis. J. Virol. 63, 4729-4735 (1989).
  78. E. Feduchi, M.A. Alonso y L. Carrasco. Human interferon gamma and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63, 1354-1359 (1989).
  79. R. Guinea, A. López-Rivas y L. Carrasco. Modification of phospho-lipase C and phospholipase A2 activities during poliovirus infection. J. Biol. Chem. 265, 21923-21927 (1989).
REVISTAS NACIONALES
  1. L. Carrasco. Direct toxicity of oil samples for mammalian cells grown in tissue culture. Trabajos reunidos del CSIC para el estudio del Síndrome Tóxico. Vol. 1, pp. 344-369 (1983).
  2. B. Rodríguez, M.V. Dabrio y L. Carrasco. Fraccionamiento de aceites presuntamente tóxicos. Trabajos reunidos del CSIC para el estudio del Síndrome Tóxico. Vol. 1, pp. 245-257 (1983).
  3. A. Muñoz y L. Carrasco. Acción del interferón linfoblastoide humano frente a la infección por virus herpes simplex tipo 1. Interferón y Biotecnología 1, 17-30 (1984).
  4. L. Carrasco, M.A. Alonso y A. Muñoz. Regulación de la traducción en células animales infectadas por virus. In "Bioquímica y Biología Molecular" (L. Leloir, S. Ochoa, J. Oró and A. Sols, eds.), pp. 398-404, Salvat (1986).
  5. B. Alarcón y L. Carrasco. Nuevas corrientes en el diseño de agentes antivirales. Rev. Esp. Microbiol. 37, 99-119 (1985).
  6. B. Alarcón y L. Carrasco. Agentes antivirales: Mecanismo de acción. Interferón y Biotecnología 2, 87-102 (1985).
  7. M.J. Otero, J.L. Castrillo y L. Carrasco. Cambios de permeabilidad en células animales infectadas por virus. Adel. Microbiol. Enf. Infecc. 5, 87-116 (1986).
  8. L. Carrasco y E. Feduchi. Los interferones. En"Etiología del Cáncer y Patología Molecular" (M. Barbacid, F. Mayor and S. Ochoa, eds.), pp. 147-171. Fundación Ramón Areces (1989).
  9. M.E. González y L. Carrasco. Acción antiviral de polisacáridos. Revista Española de Quimioterapia 1, 31-36 (1988).
  10. E. Feduchi, M.E. González y L. Carrasco. Agentes antivirales: interferones. Factor necrosante de tumores y polisacáridos naturales. Biotecnología 5, 19-21 (1989).
PUBLICACIONES EN REVISTAS INTERNACIONALES (Años 90)
  1. R. Guinea y L. Carrasco. Phospholipid biosynthesis and poliovirus genome replication: Two coupled phenomena. EMBO J. 9, 2011-2016 (1990).
  2. M.E. González, M.J. Almela, M. Yacout y L. Carrasco. 6-(3,4-Dichorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating. Ant. Ag. Chemoth. 34,1259-1261 (1990).
  3. M.E. González, F. Martínez-Abarca y L. Carrasco. Flavonoids: Potent inhibitors of poliovirus RNA synthesis. Ant. Chem. Chemoth. 1, 203-209 (1990).
  4. E. Feduchi y L. Carrasco. Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon g. Virology 180, 822-825 (1991).
  5. L. Perez y L. Carrasco. Cerulenin, an inhibitor of lipid synthesis, blocks vesicular estomatitis virus replication. FEBS Letters 280, 129-133 (1991).
  6. M.J. Almela, M.E. Gonzalez y L. Carrasco. Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles. J. Virol. 65, 2572-2577 (1991).
  7. R. Guinea y L. Carrasco. Effects of fatty acids on lipid synthesis and viral RNA replication in poliovirus-infected cells. Virology. 185, 473-476 (1991).
  8. L. Perez, R. Guinea y L. Carrasco . Synthesis of Semliki forest virus RNA requires continuous lipid synthesis. Virology 183, 74-82 (1991).
  9. J.A. López-Guerrero, F. Martinez-Abarca, M. Fresno, L. Carrasco y M.A. Alonso. Poliovirus replication takes place at different molar ratios of (-) and (+) RNA in distinct cell types.Virus Res. 20, 23-29 (1991).
  10. P. L. Rodríguez y L. Carrasco. Gliotoxin: an inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol. J. Virol. 66, 1971-1976 (1992).
  11. L. Perez y L. Carrasco. Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection. Virology. 189, 178-186 (1992).
  12. J. Lama, R. Guinea, F. Martinez-Abarca y L. Carrasco. Cloning and inducible expression of poliovirus nonstructural proteins. Gene. 117, 185-192 (1992).
  13. J. Lama y L. Carrasco. Expression of poliovirus nonstructural proteins in E. coli cells. Modification of membrane permeability induced by 2B and 3A. J. Biol. Chem. 267,15932-15937 (1992).
  14. J. Lama y L. Carrasco. Inducible expression of a toxic poliovirus membrane protein in Escherichia coli. Comparative studies using different expression systems based on T7 promoters. Biochem. Biophys. Res. Commun. 188, 972-981 (1992).
  15. A. Irurzun, L. Perez y L. Carrasco. Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A. Virology. 191, 166-175 (1992).
  16. R.W. Buckheit, E.L. White, W.M. Shannon, A. Guerrero, J.P. Pivel, L. Carrasco, J.A. Leal y M.A. Chirigos. Significant anti-HIV activity of new modified polyanionic polymers in vitro. Immunopharm. Immunother. 14, 707-721 (1992).
  17. A. Irurzun, L. Perez y L. Carrasco. Enhancement of phospholipase activity during poliovirus infection. J. Gen.Virol. 74,1063-1071 (1993).
  18. L. Pérez, A. Irurzun y L. Carrasco. Activation of phospholipase activity during simliki forest virus infection. J. Gen. Virol. 194, 28-36 (1993).
  19. P. Rodriguez y L. Carrasco. Poliovirus protein 2C has GTPase and ATPase activity. J. Biol. Chem. 268, 8105-8110 (1993).
  20. L. Perez y L. Carrasco. Entry of poliovirus into cells does not require a low-pH step. J. Virol. 67, 4543-4548 (1993).
  21. F. Martinez-Abarca, M.A. Alonso y L. Carrasco. High level expression in E. coli cells and purification of poliovirus protein 2Apro. J. Gen. Virol. 74, 2645- 2652 (1993).
  22. A. Irurzun, L. Pérez y L. Carrasco. Brefeldin A blocks protein glycosylation and RNA replication of vesicular stomatitis virus. FEBS Lett. 336, 496-500 (1993).
  23. A. Irurzun, L. Pérez y L. Carrasco. Enhancement of phospholipase activity during poliovirus infection. J. Gen. Virol. 74, 1063-1071 (1993).
  24. M.J. Almela, A. Irurzun y L. Carrasco. Orobol: an inhibitor of vesicular stomatitis virus that blocks the synthesis of viral nucleic acids and the glycosylation of G protein. Antivir. Chem. Chemother. 5, 99-104 (1994).
  25. M.A. Sanz. L. Pérez y L. Carrasco. Semliki forest virus 6K protein modifies membrane permeability after inducible espression in E. coli cells. J. Biol. Chem. 269, 12106-12110 (1994).
  26. R. Guinea y L. Carrasco. Influenza virus M2 protein modifies membrane permeability in E. coli cells. FEBS Letters 343, 242-246 (1994).
  27. L. Pérez, A. Irurzun y L. Carrasco. Action of BFA on translation in SFV-infected HeLa cells and doubly infected with poliovirus. J. Gen. Virol. 75, 2197-2203 (1994).
  28. L. Perez y L. Carrasco. Involvement of the vacuolar ATPase in animal virus entry. J. Gen. Virol. 75, 2595-2606 (1994).
  29. R. Guinea y L. Carrasco. Concanamycin A blocks influenza virus entry into cells under acidic conditions. FEBS Letters 349,327-330 (1994).
  30. P.L. Rodríguez y L. Carrasco. Nonradioactive northwestern analysis using biotinylated riboprobes. BioTech. 17, 702-705 (1994).
  31. L. Carrasco. Picornavirus Inhibitors. Pharmacol. Ther. 64, 215-290 (1994).
  32. L. Carrasco. Entry of animal viruses and macromolecules into cells. FEBS Letters 350, 152-154 (1994).
  33. R. Guinea y L. Carrasco. Concanamycin A: a powerful inhibitor of enveloped animal-virus entry into cells. Biochem. Biophys. Res. Commun.201,1270-1278 (1994).
  34. R. Aldabe y L. Carrasco. Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem Biophys. Res. Commun. 206, 64-76 (1995).
  35. L. Carrasco. Modification of membrane permeability by animal viruses. Adv. Virus Research 45, 61-112 (1995).
  36. R. Guinea y L. Carrasco. Requirement for a vacuolar proton-ATPase during entry of influenza virus into cells. J. Virol. 69, 2306-2312 (1995).
  37. A. Barco y L. Carrasco. Cloning and expression of poliovirus non-structural proteins in Saccharomyces cerevisiae. Gene 156, 19-25 (1995).
  38. P. L. Rodriguez y L. Carrasco. Poliovirus protein 2C contains two regions involved in RNA binding activity. J. Biol. Chem. 270,10105-10112 (1995).
  39. J. Lama y L. Carrasco. Mutations in the hydrophobic domain of poliovirus protein 3AB abrogate its permeabilizing activity. FEBS Letters. 367, 5-11 (1995).
  40. I. Novoa, E. Feduchi y L. Carrasco. Hybrid proteins between Pseudomonas exotoxin A and poliovirus protease 2Apro. FEBS Letters 355, 45-48 (1994).
  41. J. Arroyo, M. Boceta, M.E. González, M. Michel y L. Carrasco. Membrane permeabilization by different regions of the HIV-1 transmembrane glycoprotein gp41. J. Virol. 69, 4095-4102 (1995).
  42. A. Barco y L. Carrasco. A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae. EMBO J. 14, 3349-3364 (1995).
  43. P. L. Rodríguez y L. Carrasco. Improved factor Xa cleavage of fusion proteins containing maltose binding protein. BioTechniques 18, 238-243 (1995).
  44. I. Ventoso y L. Carrasco. A poliovirus 2Apro mutant unable to cleave 3CD shows inefficient viral protein synthesis. J. Virol. 69, 6280-6288 (1995).
  45. A. Irurzun, J. Arroyo, A. Alvarez y L. Carrasco. Enhanced intracellular calcium during poliovirus infection. J. Virol. 69, 5142-5146 (1995).
  46. A. Irurzun, S. Sanchez-Palomino, I. Novoa y L. Carrasco. Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage. J. Virol. 69, 7453-7460 (1995).
  47. E. Feduchi, R. Aldabe, I. Novoa y L. Carrasco. Effects of Poliovirus 2Apro on vaccinia virus gene expression . Eur. J. Biochem. 234, 849-854 (1995).
  48. A. Barco y L. Carrasco. Poliovirus 2Apro expression inhibits growth of yeast cells. FEBS Letters. 371, 4-8 (1995).
  49. R. Aldabe, E. Feduchi, I. Novoa y L. Carrasco. Efficient cleavage of p220 by poliovirus 2Apro expression in mammalian cells. Effects on vaccinia virus. Biochem. Biophys. Res. Commun. 215, 928-936 (1995).
  50. R. Aldabe, E. Feduchi, I. Novoa y L. Carrasco. Expression of poliovirus 2Apro in mammalian cells. Effects on translation. FEBS Letters. 377, 1-5 (1995).
  51. M.C. García Martínez, R. Guinea, J. Benavente y L. Carrasco. The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity. J. Virol. 70, 576-579 (1996).
  52. A. Echarri, M.E. González y L. Carrasco. Human immunodeficiency virus (HIV) nef is an RNA binding protein in cell-free systems. J. Mol. Biol. 262, 640-651 (1996).
  53. I. Novoa, M. Cotten y L. Carrasco. Hybrid proteins between Pseudomonas exotoxin A and poliovirus 2Apro cleave p220 in HeLa cells. J. Virol. 70, 3319-3324 (1996).
  54. J. Lama y L. Carrasco. Screening for membrane-permeabilzation mutants of the poliovirus protein 3AB. J. Gen. Virol. 77, 2109-2119 (1996).
  55. R. Aldabe, A. Barco y L. Carrasco. Membrane permeabilization by poliovirus proteins 2B and 2BC. J. Biol. Chem. 271, 23134-23137 (1996).
  56. A.Irurzun, J.L. Nieva y L. Carrasco. Entry of Semliki Forest virus into cells: effects of concanamycin A and nigericin on viral membrane fusion and infection. Virology 227, 488-492 (1997).
  57. I. Novoa, J. Benavente, M. Cotten y L. Carrasco. Permeabilization of mammalian cells to proteins: Poliovirus 2Apro as a probe to analyze entry of proteins into cells. Exp. Cell Res. 232, 186-190 (1997).
  58. A. Echarri, M.E. González y L. Carrasco. The N-terminal Arg-rich region of human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef is involved in RNA binding. Eur. J. Biochem. 246, 38-44 (1997).
  59. I.V. Sandoval y L. Carrasco. Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly og the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J. Virol. 71, 4679-4693 (1997).
  60. R. Aldabe, A. Irurzun y L. Carrasco. Poliovirus protein 2BC increases cytosolic free calcium concentrations. J. Virol. 71, 6214-6217 (1997).
  61. I. Novoa, F. Martínez-Abarca, P. Fortes, J. Ortín y L. Carrasco. Cleavage of p220 by purified poliovirus 2Apro in cell-free systems. Effects on translation of capped and uncapped mRNAs. Biochemistry 36, 7802-7809 (1997).
  62. A. Barco, I. Ventroso y L. Carrasco. The yeast Saccharomyces cerevisiae as a genetic system for obtaining variants of poliovirus protease 2A". J. Biol. Chem. 272, 12683-12691 (1997).
  63. M. Pérez, B. García-Barreno, J.A. Melero, L. Carrasco y R. Guinea. Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncitial virus. Virology 235, 342-351 (1997).
  64. M.J. Abad, P. Bermejo, A. Villar, S. Sánchez Palomino y L. Carrasco. Antiviral activity of medicinal plant extracts. Phytotherapy Res. 11, 198-202 (1997).
  65. J.A. López-Guerrero y L. Carrasco. Effect of nitric oxide on poliovirus infection of two human cell lines. J. Virol. 72, 2538-2540 (1998).
  66. A. Barco y L. Carrasco. Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity. J. Virol. 72, 3560-3570(1998).
  67. J. Lama, M.A. Sanz y L. Carrasco. Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells. J. Gen. Virol. 79, 1911-1921 (1998).
  68. I. Ventoso, S.E. MacMillan, J.W.B. Hershy y L. Carrasco. Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-4F complex. Febs Lett. 435, 79-83 (1998).
  69. M.E. González y L. Carrasco. The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability. Biochemistry 37, 13710-13719 (1998).
  70. I. Ventoso, A. Barco y L. Carrasco. Mutational analysis of poliovirus 2Apro. J. Biol. Chem. 273, 27960-27967 (1998).
  71. A. Barco y L. Carrasco. Co-expression of human eIF-4G and poliovirus 2Apro in Saccharomyces cerevisiae: effects on gene expression. J. Gen. Virol. 79, 2651-2660 (1998).
  72. I. Ventoso, A. Barco y L. Carrasco. Genetic selection of poliovirus 2Apro-binding peptides. J. Virol. 73,814-818 (1999).
  73. I. Novoa y L. Carrasco. Cleavage of eukaryotic translation initiation factor 4G by exogenously added hybrid proteins containing poliovirus 2Apro in HeLa cells: effects on gene expression. Mol. Cell. Biol. 19, 2445-2459 (1999).
REVISTAS NACIONALES
  1. L. Carrasco. El virus del SIDA: Terapias para combatir el VIH. Enferm. Infecc. Microbiol. 9, 540-549 (1995).
PUBLICACIONES EN REVISTAS INTERNACIONALES (Años 2000)
  1. A. Barco, E. Feduchi y L. Carrasco. Poliovirus protease 3Cpro kills cells by apoptosis. Virology 266, 352-360 (2000).
  2. F. Martín-Belmonte, J.A. López-Guerrero, L. Carrasco y M.A. Alonso. The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes. Biochemistry 39, 1083-1090 (2000).
  3. A. Barco, E. Feduchi y L. Carrasco. A stable HeLa cell line that inducibly expresses poliovirus 2Apro: Effects on cellular and viral gene expression. J. Virol. 74, 2383-2392 (2000).
  4. J.A. López-Guerrero, M. Alonso, F. Martín-Belmonte y L. Carrasco. Poliovirus induces apoptosis in the human U937 promonocytic cell line.Virology 272, 250-256 (2000).
  5. T. Aragón, S. de la Luna, I. Novoa, L. Carrasco, J. Ortín y A. Nieto. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol. Cell. Biol. 20, 6259-6268 (2000).
  6. A. Echarri, M.E. González, I. Ventoso y L. Carrasco. Nonradioactive methods for the detection of RNA-protein interaction. The Nucleic Acid Protocols Handbook. Edited by R. Rapley. Humana Press, Totowa, New Jersey. pp. 783-791 (2000).
  7. M.E.González y L. Carrasco. Human immunodeficiency virus type 1 Vpu protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization. Virology 279, 201-209 (2001).
  8. A. Irurzun y L. Carrasco. Entry of poliovirus into cells is blocked by valinomycin and concanamycin A. Biochemistry 40, 3589-3600 (2001).
  9. M.A. Sanz y L. Carrasco. A Sindibis virus variant with a deletion in the 6K gene shows defects in glycoprotein processing and trafficking. Lack of complementation by a wild-type 6K gene in trans. J. Virol. 75, 7778-7784 (2001).
  10. I. Ventoso, R. Blanco, C. Perales y L. Carrasco. HIV-protease cleaves eukaryotic factor 4G and inhibits cap-dependent translation. Proc. Nat. Acad. Sci. USA 98, 12966-12971 (2001).
  11. P. Bermejo, M.J. Abad, A.M. Diaz, L. Fernández, J.D. Santos, S. Sánchez, L. Villaescusa, y L. Carrasco y A. Irurzun. Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupléurum rigidum and scrophularia scorodonia. Planta Med. 68, 106-110 (2002).
  12. V. Robin, A. Irurzun, M. Amoros, J. Boustie y L. Carrasco. Antipoliovirus flavonoids from Psiadia dentata. Antiviral Chemistry and Chemotherapy 12, 283-291 (2002).
  13. A. Agirre, A. Barco, L. Carrasco y J.L. Nieva. Viroporin-mediated membrane permeabilization: pore formation by non-structural poliovirus 2B protein. J. Biol. Chem. 277, 40434-40441 (2002).
  14. R. Blanco, L. Carrasco e I. Ventoso. Cell killing by HIV-1 protease. J Biol Chem. 278, 1086-1093 (2003).
  15. M.A. Sanz, M.T. Rejas y L. Carrasco. Individual expression of Sindbis virus glycoproteins. E1 alone promotes cell fusion. Virology 305, 463-472 (2003).
  16. M.A. Sanz, V. Madan, L. Carrasco y J.L. Nieva. Interfacial domains in Sindbis virus 6K protein: detection and functional characterization. J. Biol. Chem. 278, 2051-2057 (2003).
  17. C. Perales, L. Carrasco e I. Ventoso. Cleavage of eIF4G by HIV-1 protease: Effects on translation. FEBS Letters, 533, 89-94 (2003).
  18. M.E. González y L. Carrasco. Viroporins. FEBS Letters 552, 28-34 (2003). 191. J.L. Nieva, A. Aguirre, S. Nir y L. Carrasco. Mechanisms of membrane permeabilization by picornavirus 2B viroporin. FEBS Letters 552, 68-73 (2003).
  19. E. Alvarez, L. Menendez y L. Carrasco. The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. J. Virol. 77, 12392-12400 (2003).
  20. C. Calandria, A. Irurzun, A. Barco y L. Carrasco. Individual expression of poliovirus 2Apro and 3Cpro induces activation of caspase-3 and PARP cleavage in HeLa cells. Virus Research 104, 39-49 (2004).
  21. J.L. Nieva, M.A. Sanz y L. Carrasco. Membrane-permeabilizing motif in Semliki Forest virus E1 glycoprotein. FEBS Lett. 576, 417-422 (2004).
  22. V. Madan, M.A. Sanz y L. Carrasco. Requirement of the vesicular system for membrane permeabilization by Sindbis virus. Virology, 332, 307-315 (2005).
  23. C. Perales, L. Carrasco y M.E. González. Regulation of HIV-1 env mRNA translation by Rev protein. Biochem. Biophys. Acta 1743, 169-175 (2005).
  24. I. Ventoso, J. Navarro, M.A. Muñoz y L. Carrasco. Involvement of HIV-1 protease in virus-induced cell killing. Antiviral Research 66, 47-55 (2005).
  25. L. Carrasco, M. Ramos, R. Galisteo, D. Pisa, M. Fresno y M.E. González. Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J. Clin. Microbiol. 43 (2), 1730-1734 (2005).
  26. V. Madan, M. de Jesús, M.A. Sanz y L. Carrasco. Viroporin activity of murine hepatitis virus E. protein. FEBS Lett. 579, 3607-3612 (2005).
  27. A. Castelló, M.A. Sanz, S. Molina y L. Carrasco. Translation of Sindbis virus 26S mRNA does not require intact eukaryotic initiation factor 4G. J. Mol. Biol. 355, 942-956 (2006).
  28. I. Ventoso, M.A. Sanz, S. Molina, J.J. Berlanga, L. Carrasco y M. Esteban. Translational resistance of late alphavirus mRNA to eIF2a phosphorylation: A strategy to overcome the antiviral effect of protein kinase PKR. Genes and Development 20, 87-100 (2006).
  29. J. Berlanga, I. Ventoso, H.P. Harding, J. Deng, D. Ron, N. Sonenberg, L. Carrasco y C. de Haro. Antiviral effect of the mammalian translation initiation factor 2a kinase GCN2 against RNA viruses. EMBO J. 25, 1730-1740 (2006).
  30. E. Alvarez, A. Castelló, L. Menéndez-Arias y L. Carrasco. HIV protease cleaves poly(A) binding protein. Biochem. J. 396, 219-226 (2006).
  31. A. Castelló, E. Alvarez y L. Carrasco. Differential cleavage of eIF4GI and eIF4GII in mammalian cells. Effects on translation. J. Biol. Chem. 281, 33206-33216 (2006).
  32. D. Pisa, M. Ramos, S. Molina, P. García y L. Carrasco. Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata. J. Med. Microbiol. 56, 571-578 (2007).
  33. M.A. Sanz, A. Castelló y L. Carrasco. Viral translation is coupled to transcription in Sindbis virus-infected cells. J. Virol. 81, 7061-7068 (2007).
  34. S. Molina, M.A. Sanz, V. Madan, I. Ventoso, A. Castelló y L. Carrasco. Differential inhibition of cellular and Sindbis virus translation by Brefeldin A. Virology 363, 430-436 (2007).
  35. M. Pacheco, P. García-Gómez, L. Carrasco y A. Juarranz. Attachment and entry of Candida famata in monocytes and epithelial cells. Microscopy Res. Tech. 70, 975-986 (2007).
  36. V. Madan, S. Sánchez-Martínez, N. Vedovato, G. Rispoli,. L. Carrasco y J.L. Nieva. Plasma membrane-porating domain in poliovirus 2B protein. A short peptide mimics viroporin activity. J. Mol. Biol. 374, 951-964 (2007).
  37. V. Madan, A. Castelló y L. Carrasco. Viroporins from RNA viruses induce caspase-dependent apoptosis. Cell Microbiol. 10, 437-451 (2008).
  38. Pisa, D., M. Ramos, P. García, R. Escoto, R. Barraquer, S. Molina y L. Carrasco. Fungal infection in patients with Serpiginous choroiditis or acute zonal occult outer retinopathy. J. Clin. Microbiol. 46, 130-135 (2008).
  39. M. Ramos, D. Pisa, S. Molina, A. Rábano, A. Juarranz y L. Carrasco. Fungal infection in patients with multiple sclerosis. The Open Mycology J. 2, 22-28 (2008).
  40. Sánchez-Martínez, S., Huarte, N., Maeso, R., Madan, V., Carrasco, L., and Nieva, J.L. Functional and structural characterization of 2B viroporin membranolytic domains. Biochemistry 47, 10731-10739 (2008).
  41. Sanz, M.A., Castelló, A., Ventoso, I., Berlanga, J. and Carrasco, L. Dual mechanism for the initiation of translation of subgenomic mRNA from Sindbis virus in infected and uninfected cells. PLoS ONE 4, e4772 (2009).
  42. Castelló, A., Quintas, A., Sánchez, E.G., Sabina, P., Nogal, M., Carrasco, L. and Revilla, Y. Regulation of host translational machinery by African swine fever virus. PLoS Pathog. 5, e1000562 (2009).
  43. Castelló, A., Izquierdo, J.M., Welnowska, E. and Carrasco, L. RNA nuclear export is blocked by poliovirus 2A protease and is concomitant with nucleoporin cleavage. J. Cell Sci. 122, 3799-3809 (2009).
  44. Welnowska, E., Castelló, A., Moral, P. and Carrasco, L. Translation of mRNAs from vesicular stomatitis virus and vaccinia virus is differentially blocked in cells with depletion of eIF4GI and/or eIF4GII. J. Mol. Biol. 394, 506-521(2009).
  45. Castelló, A., Franco, D., Berlanga, J.J., Alvarez, E., Wimmer, E. and Carrasco, L. HIV- 1 protease inhibits cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. PLOs ONE 4, e7977 (2009).
  46. Madan, V., Sánchez-Martínez, S., Carrasco, L. and Nieva, J.L. A peptide based on the pore-forming domain of pro-apoptotic poliovirus 2B viroporin targets mitochondria. Biochim. Biophys. Acta 1798, 52-58 (2010).
  47. Madan, V., Redondo, N. and Carrasco, L. Cell permeabilization by poliovirus 2B viroporin triggers bystander permeabilization in neighbouring cells through a mechanism involving gap junctions. Cell. Microbiol. 12, 1144-1157 (2010).
  48. Benito-Leon, J., Pisa, D., Alonso, R., Calleja, P., Díaz-Sánchez, M. and Carrasco, L. Association between multiple sclerosis and candida species: evidence from a case-control study. European Journal of Clinical Microbiology & Infectious Diseases. 29, 1139-1145 (2010).
  49. Sanz, M.A., Welnowska, E., Redondo, N. and Carrasco, L. Translation driven by picornavirus IRES is hampered from Sindbis virus replicons: Rescue by poliovirus 2A protease. J. Mol. Biol. 402, 101-117 (2010).
  50. Yángüez, E., Castelló, A., Welnowska, E., Carrasco, L., Goodfellow, I. and Nieto, A. 2011. Functional impairment of eIF4A and eIF4G factors correlates with inhibition of influenza virus mRNA translation. Virology 413, 93-102. 2011.
  51. Pisa, D., Alonso, R. and Carrasco, L. Fungal infection in a patient with multiple sclerosis. Eur. Clin. Microbiol. Infect. Dis. 30, 1173-1180. 2011.
  52. Castelló, A., Alvarez, E. and Carrasco, L. The multifaceted poliovirus 2A protease. Regulation of gene expression by picornavirus proteases. J. Biomed. Biotechnol. 2011:369648. 2011.
  53. Welnowska, E., Sanz, M.A., Redondo, N. and Carrasco, L. Translation of viral mRNA without active eIF2: the case of picornaviruses. PLos One, 6(7):e22230. 2011.
  54. E. Alvarez, A. Castelló, L. Carrasco and J.M. Izquierdo. Alternative splicing, a new target to block cellular gene expression by poliovirus 2A protease. Biochem. Biophys. Res. Commun. 414, 142-147. 2011.
  55. Martínez-Gil, L., Bañó-Polo, M., Redondo, N., Sánchez-Martínez, S., Nieva, J.L., Carrasco, L. and Mingarro, I. Membrane integration of poliovirus 2B viroporin. J. Virol. 85, 11315-11324. 2011.
  56. Redondo, N., Sanz, M.A., Welnowska, E. and Carrasco, L. Translation without eIF2 promoted by poliovirus 2A protease. PLoS One 6, e25699. 2011.
  57. Buzón, M.J., Erkizia, I., Pou, C., Minuesa, G., Puertas, M.C., Esteve, A., Castelló, A., Santos, J.R., Prado, J.G., Izquierdo-Useros, N., Pattery, T., Van Houtte, M., Carrasco, L., Clotet, B., Ruiz, L., and Martinez-Picado, J. A Non-infectious Cell-based Phenotypic Assay for the Assessment of HIV-1 Susceptibility to Protease Inhibitors. J Antimicrob Chemother. 67(1):32-38. 2012.
  58. Nieva, J.L., Madan, V. and Carrasco, L. Viroporins: structure and biological functions. Nature Rev. Microbiol. 10, 563-574, 2012.
  59. Sánchez-Martínez, S., Madan, V., Carrasco, L. and Nieva, J.L. Membrane-active peptides derived from picornavirus 2B viroporin. Current Protein Pept. Sci. 13, 632-643 (2012).
  60. Redondo, N., Sanz, M.A., Steinberger, J., Skern, T., Kousov, Y. and Carrasco, L. Translation directed by hepatitis A virus IRES in the absence of active eIF4F complex and eIF2. PLoS One 7(12): e52065. 2012.
  61. García-Moreno, M., Sanz, M.A., Pelletier, J. and Carrasco, L. Requirements for eIF4A and eIF2 during translation of Sindbis virus subgenomic mRNA in vertebrate and invertebrate host cells. Cellular Microbiology 15(5) 823-840. 2013.
  62. Sanz, M.A., Redondo, N., García-Moreno, M. and Carrasco, L. Phosphorylation of eIF2 is responsible for the failure of the picornavirus internal ribosome entry site to direct translation from Sindbis virus replicons. J. Gen. Virol. 94(Pt 4), 796-806, 2013.
  63. Linero, F., Welnowska, E.,Carrasco, L., Scolaro, L. Participation of eIF4F complex in Junin virus infection: blockage of eIF4E does not impair virus replication. Cellular Microbiology 15(10) 1766-1782. 2013.
  64. Pisa D, Alonso R, Jiménez-Jiménez FJ, Carrasco L. Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis. Eur J Clin Microbiol Infect Dis. 32(6), 795-801. 2013.
  65. Redondo, N., Garcia Moreno, M., Sanz, M.A., Carrasco, L. Translation of viral mRNAs that do not require eIF4E is blocked by the inhibitor 4EGI-1. Virology 444(1-2) 171-180. 2013.
  66. Alvarez, E., Castelló, A., Carrasco, L., Izquierdo, J.M. Poliovirus 2A protease triggers a selective nucleo-cytoplasmic redistribution of splicing factors that regulates alternative pre-mRNA splicing. PLoS ONE 16;8(9):e73723. 2013.
  67. Alonso, R., Pisa, D., Rábano, A., Carrasco, L. Alzheimer’s disease and disseminated mycoses. Eur. J. Clin. Microbiol. Infect. Dis. Jan. 33(7):1125-32.2014.
  68. Alonso, R., Pisa, D., Marina, A.I., Morato, E., Rábano, A., Carrasco, L. Fungal infection in patients with Alzheimer’s disease. J. Alzheimers Dis. 41(1):301-311. 2014.
  69. Moral-López, P., Alvarez, E., Redondo, N., Skern, T., Carrasco, L. L-protease from foot and mouth disease virus confers eIF2-independent translation for mRNAs bearing picornavirus IRES. FEBS Lett. 588(21):4053-4059. 2014.
  70. Sanz, M.A., García-Moreno, M., Carrasco, L. Inhibition of host protein synthesis by Sindbis virus: correlation with viral RNA replication and release of nuclear proteins to the cytoplasm. Cell Microbiol. 17(4):520-541. 2015.
  71. García-Moreno, M., Sanz, M.A., Carrasco, L. Initiation codon selection is accomplished by a scanning mechanism without crucial initiation factors in Sindbis virus subgenomic mRNA. RNA 21(1): 93-112. 2015.
  72. Pisa, D., Alonso, R., Juarranz, A., Rábano, A., Carrasco, L. Direct visualization of fungal infection in brains from patients with Alzheimer’s disease. J. Alzheimers Dis. 43(2): 613-624. 2015.
  73. Alonso, R., Pisa, D., Marina, A.I., Morato, E., Rábano, A., Rodal, I., Carrasco, L. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis. International J. Biol. Sci. 11, 546-558. 2015.
  74. González-Almela, E., Sanz, M.A., García-Moreno, M., Northcote, P., Pelletier, J., Carrasco, L. Differential action of pateamine A on translation of genomic and subgenomic mRNAs from Sindbis virus. Virology 484, 41-50. 2015.
  75. Redondo, N., Madan, V., Alvarez, E., Carrasco, L. Impact of vesicular stomatitis virus M proteins on different cellular functions. PLoS One 10(6):e0131137. 2015.
  76. Alonso, R., Pisa, D., Rábano, A., Rodal, I., Carrasco, L. Cerebrospinal fluid from Alzheimer’s disease patients contains fungal proteins and DNA. J. Alzheimers Dis. 47, 873-876. 2015.
  77. Pisa, D. Alonso, R., Rábano, A., Rodal, I. and Carrasco, L. Different brain regions are infected with fungi in Alzheimer’s disease. Sci. Rep. 5, 15015. 2015.
  78. Nieva, J.L. and Carrasco, L. Viroporins: Structures and functions beyond cell membrane permeabilization. Special Issue Viruses, 7,(10) 5169–5171. 2015.
  79. Monroy, N., Herrero, L., Carrasco, L. and González, M.E. Influence of glutathione availability on cell damage induced by human immunodeficiency virus type 1 viral protein R. Virus Research. 213: 116-123. 2015.
  80. García-Moreno, M., Sanz, M.A. and Carrasco, L. A viral mRNA motif at the 3’-untranslated region that confers translatability in a cell-specific manner. Implications for virus evolution. Sci. Reports. Jan 12; 6: 19217. 2016.
  81. Pisa, D., Alonso, R., Rábano, A., Carrasco, L. Corpora amylacea of brain tissue from neurodegenerative diseases are stained with specific antifungal antibodies. Frontiers Neurosc. Mar 8; 10; 86. 2016.
  82. Pisa, D., Alonso, R., Rábano, A., Horst, M., Carrasco. L. Fungal enolase, &beta-tubulin and chitin are detected in brain tissue from Alzheimer’s disease patients. Frontiers in Microbiology, 7: 1772. 2016.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

ACEPTAR